Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, September 11 - Friday, September 15, 2023), and click each link to read and watch anything you may have missed.
1.) Vulvovaginal emergencies: diagnosis and treatment
Jermaine Gray, MD, provides some essential tips for various cases of vulvovaginal conditions that present in the emergency department, which was recently presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting.
Click here for the full article.
2.) The potential of ketamine to mitigate postpartum depression
Results from a case study analysis submitted during the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois, highlight the potential of ketamine as a potential alternative to traditional antidepressants for postpartum depression (PPD) treatment.
Click here for the full article.
3.) Long-acting reversible contraception access for a Southern Texas border population
The IPP LARC program “allowed for the provision of LARCs for women who had limited to no funds or access, especially in the postpartum period,” according to study authors of a poster presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.
Click here for the full article.
4.) Recognizing the importance of aesthetics in cesarean section closures
In a poster featured at the 2023 Society for OB/GYN Hospitalists Annual Clinical Meeting, study investigators underline the importance of aesthetics in cesarean section closures as both providers and patients.
Click here for the full article.
5.) Reducing postpartum length of stay following vaginal or cesarean delivery
A targeted, collaborative approach to reduce length of stay (LOS) after cesarean or vaginal delivery resulted in a significant and sustained decrease in mean postpartum LOS without compromising patient safety, according to a poster featured at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting, held in Chicago, Illinois.
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More